【参考資料4】抗微生物薬適正使用の手引き 第三版 本編 (54 ページ)
出典
公開元URL | https://www.mhlw.go.jp/stf/newpage_45318.html |
出典情報 | 厚生科学審議会 感染症部会 薬剤耐性(AMR)に関する小委員会 抗微生物薬適正使用(AMS)等に関する作業部会(第6回 11/19)《厚生労働省》 |
ページ画像
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
第三版
35. Bisno AL, Gerber MA, Gwaltney JM, Kaplan EL, Schwartz RH. Practice Guidelines for the
Diagnosis and Management of Group A Streptococcal Pharyngitis. Clin Infect Dis.
2002;35(2):113-125.
36. Tanz RR, Shulman ST. Chronic pharyngeal carriage of group A streptococci. Pediatr Infect
Dis J. 2007;26(2):175-176.
37. Aliyu SH, Marriott RK, Curran MD, Parmar S, Bentley N, Brown NM, Brazier JS, Ludlam H.
Real-time PCR investigation into the importance of Fusobacterium necrophorum as a cause
of acute pharyngitis in general practice. J Med Microbiol. 2004;53(Pt 10):1029-1035.
38. Batty A, Wren MW. Prevalence of Fusobacterium necrophorum and other upper respiratory
tract pathogens isolated from throat swabs. Br J Biomed Sci. 2005;62(2):66-70.
39. Amess JA, O'Neill W, Giollariabhaigh CN, Dytrych JK. A six-month audit of the isolation of
Fusobacterium necrophorum from patients with sore throat in a district general hospital. Br J
Biomed Sci. 2007;64(2):63-65.
40. Centor RM, Geiger P, Waites KB. Fusobacterium necrophorum bacteremic tonsillitis: 2
Cases and a review of the literature. Anaerobe 2010;16(6):626-628.
41. Shah M, Centor RM, Jennings M. Severe acute pharyngitis caused by group C
streptococcus. J Gen Intern Med. 2007;22(2):272-274.
42. Centor RM. Expand the pharyngitis paradigm for adolescents and young adults. Ann Intern
Med. 2009;151(11):812-815.
43. Jensen A, Hansen TM, Bank S, Kristensen LH, Prag J. Fusobacterium necrophorum
tonsillitis: an important cause of tonsillitis in adolescents and young adults. Clin Microbiol
Infect. 2015;21(3):266.e1-266.e3.
44. Hedin K, Bieber L, Lindh M, Sundqvist M. The aetiology of pharyngotonsillitis in adolescents
and adults - Fusobacterium necrophorum is commonly found. Clin Microbiol Infect.
2015;21(3):263.e1-263.e7.
45. Centor RM, Atkinson TP, Ratliff AE, Xiao L, Crabb DM, Estrada CA, Faircloth MB, Oestreich
L, Hatchett J, Khalife W, Waites KB. The Clinical Presentation of Fusobacterium-Positive and
Streptococcal-Positive Pharyngitis in a University Health Clinic: A Cross-sectional Study. Ann
Intern Med. 2015;162(4):241-247.
46. McIsaac WJ, Kellner JD, Aufricht P, Vanjaka A, Low DE. Empirical validation of guidelines for
the management of pharyngitis in children and adults. JAMA. 2004;291(13):1587-1595.
47. McIsaac WJ, Goel V, To T, Low DE. The validity of a sore throat score in family practice. Can
Med Assoc J. 2000;163(7):811-815.
48. ESCMID Sore Throat Guideline Group, Pelucchi C, Grigoryan L, et al. Guideline for the
management of acute sore throat. Clin Microbiol Infect. 2012;18 Suppl 1:1-28.
49. JAID/JSC 感染症治療ガイド・ガイドライン作成委員会. JAID/JSC 感染症治療ガイド 2014.
東京: ライフサイエンス出版; 2014.
50. McGinn TG, Deluca J, Ahlawat SK, Mobo BH, Wisnivesky JP. Validation and modification of
streptococcal pharyngitis clinical prediction rules. Mayo Clin Proc. 2003;78(3):289-293.
51. Humair J-P, Revaz SA, Bovier P, Stalder H. Management of acute pharyngitis in adults:
reliability of rapid streptococcal tests and clinical findings. Arch Intern Med. 2006;166(6):640644.
54